Mark Holloway is a partner working out of Wilson Sonsini Goodrich & Rosati's Washington, D.C., office, where he counsels public and private technology and life sciences companies through all stages of growth. Mark is a part of the firm's mergers and acquisitions practice, and he focuses on strategic transactions, including mergers, acquisitions, divestitures, carveouts, joint ventures, and minority investments. He also counsels companies on corporate and securities law and securities exchange rules.
Mark was an adjunct professor at the Georgetown University School of Law from 2012 to 2017, where he taught a seminar on negotiation.
Prior to joining the firm, Mark was an associate in the New York office of Davis Polk & Wardwell LLP.
Mark Holloway is a partner working out of Wilson Sonsini Goodrich & Rosati's Washington, D.C., office, where he counsels public and private technology and life sciences companies through all stages of growth. Mark is a part of the firm's mergers and acquisitions practice, and he focuses on strategic transactions, including mergers, acquisitions, divestitures, carveouts, joint ventures, and minority investments. He also counsels companies on corporate and securities law and securities exchange rules.
Mark was an adjunct professor at the Georgetown University School of Law from 2012 to 2017, where he taught a seminar on negotiation.
Prior to joining the firm, Mark was an associate in the New York office of Davis Polk & Wardwell LLP.
- J.D., Harvard Law School
- A.B., Government, Georgetown University
- Named to the 2017 and 2018 editions of the “Rising Stars” list published by Washington DC Super Lawyers
- Bar of the District of Columbia
- State Bar of New York
- J.D., Harvard Law School
- A.B., Government, Georgetown University
- Named to the 2017 and 2018 editions of the “Rising Stars” list published by Washington DC Super Lawyers
- Bar of the District of Columbia
- State Bar of New York
Select Representations
- Serial acquisition and minority investment programs for public and private companies, including Danaher Corporation, FLIR Systems, InterDigital, Gartner, Nuance Communications, Sustainable Development Capital (SEEIT), United Therapeutics, and Waymo
- Sale and de-SPAC transactions for U.S. and non-U.S. companies, including Babylon Health, Careem, Current Health, Ease, Emarsys, FuboTV, Kerecis, Peakon, The Roald Dahl Story Company Limited, TVSquared, and WaveOptics
Select Representations
- Serial acquisition and minority investment programs for public and private companies, including Danaher Corporation, FLIR Systems, InterDigital, Gartner, Nuance Communications, Sustainable Development Capital (SEEIT), United Therapeutics, and Waymo
- Sale and de-SPAC transactions for U.S. and non-U.S. companies, including Babylon Health, Careem, Current Health, Ease, Emarsys, FuboTV, Kerecis, Peakon, The Roald Dahl Story Company Limited, TVSquared, and WaveOptics
Select Publications
- Co-author, "More Than a Number: The Factors in a Successful M&A Deal & How To Make Them Work," The VC Guide to Mergers & Acquisitions, Notion, March 2022
Select Speaking Engagements
- Speaker, "Fall M&A Bootcamp: The Ultimate Guide to Mergers & Acquisitions - Growth Through Acquisition: Buy Side Overview and Insights Panel," Nasdaq Entrepreneurial Center, September 27, 2023
- Speaker, "Strategic Alternatives for Life Sciences Companies in US and Europe," Life Sciences VC GC & CCO Annual Conference, June 15, 2023
- Speaker, "M&A Bootcamp: The Ultimate Guide to Mergers & Acquisitions - M&A Strategy for Early to Mid-Stage Entrepreneurs," Nasdaq Entrepreneurial Center, October 19, 2022
Select Publications
- Co-author, "More Than a Number: The Factors in a Successful M&A Deal & How To Make Them Work," The VC Guide to Mergers & Acquisitions, Notion, March 2022
Select Speaking Engagements
- Speaker, "Fall M&A Bootcamp: The Ultimate Guide to Mergers & Acquisitions - Growth Through Acquisition: Buy Side Overview and Insights Panel," Nasdaq Entrepreneurial Center, September 27, 2023
- Speaker, "Strategic Alternatives for Life Sciences Companies in US and Europe," Life Sciences VC GC & CCO Annual Conference, June 15, 2023
- Speaker, "M&A Bootcamp: The Ultimate Guide to Mergers & Acquisitions - M&A Strategy for Early to Mid-Stage Entrepreneurs," Nasdaq Entrepreneurial Center, October 19, 2022
Both platforms will capitalize on proprietary tech, AI capabilities, and expanded resources to further expand in the U.S. The acquisition will see TravelPerk double its revenue in the U.S., following 65 percent year-over-year growth in the market in 2023. TravelPerk’s U.S.-based headcount and footprint expands to now include offices in Boston, Chicago, Los Angeles, and Miami. AmTrav will operate under the same brand, and the entire team will continue with the business going forward.
- Privacy Policy
- Terms of Use
- Accessibility